Experts Offer Their Advice On Turning Science Into Business

What does it take to succeed in an entrepreneurial scientific venture? Following are some pointers from scientists who have prospered as entrepreneurs and others who have helped scientists scratch their entrepreneurial itches: * "You should identify the niche you want to be in and have the scientific expertise and inside information as to how you can build the niche adequately," says Robert Zipkin, president of Biomol Research Laboratories Inc. of Plymouth Meeting, Pa. Zipkin founded and inco

Written byLisa Simon
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

* "You should identify the niche you want to be in and have the scientific expertise and inside information as to how you can build the niche adequately," says Robert Zipkin, president of Biomol Research Laboratories Inc. of Plymouth Meeting, Pa.

Zipkin founded and incorporated Biomol in 1983, a year before he finished his Ph.D. in synthetic organic chemistry at the University of Pennsylvania. He and his partner, Ira Taffer, a fellow student from his undergraduate days at Drexel University, were confident that there was a healthy market for certain commercially unavailable organic compounds, such as leukotrienes, biologically active compounds that function as regulators of allergic and inflammatory reactions. Traditionally, academic labs created these compounds and gave them to other academic researchers; alternatively, professors acting as consultants to pharmaceutical firms gave them to clients.

Zipkin developed expertise in building leukotrienes at the bench in graduate school. While he never conducted ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies